Cargando…

The Potential Adjuvanticity of CAvant(®)SOE for Foot-and-Mouth Disease Vaccine

Foot-and-mouth disease (FMD) is a notifiable contagious disease of cloven-hoofed mammals. A high potency vaccine that stimulates the host immune response is the foremost strategy used to prevent disease persistence in endemic regions. FMD vaccines comprise inactivated virus antigens whose immunogeni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Young-Hoon, Chathuranga, W. A. Gayan, Shim, Young-Jung, Haluwana, D. K., Kim, Eun-Hee, Yoon, In-Joong, Lim, Yong-Taik, Shin, Sung Ho, Jo, Hyundong, Hwang, Seong Yun, Kim, Hyun Mi, Lee, Min Ja, Park, Jong-Hyeon, Yoo, Sung-Sik, Lee, Jong-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539697/ https://www.ncbi.nlm.nih.gov/pubmed/34696199 http://dx.doi.org/10.3390/vaccines9101091

Ejemplares similares

CAvant® WO-60 as an Effective Immunological Adjuvant for Avian Influenza and Newcastle Disease Vaccine
por: Lee, Eun-Seo, et al.
Publicado: (2021)

Efficacy of a Novel Multiepitope Vaccine Candidate against Foot-and-Mouth Disease Virus Serotype O and A
por: Chathuranga, W. A. Gayan, et al.
Publicado: (2022)

Mincle and STING-Stimulating Adjuvants Elicit Robust Cellular Immunity and Drive Long-Lasting Memory Responses in a Foot-and-Mouth Disease Vaccine
por: Lee, Min Ja, et al.
Publicado: (2019)

Improved immune responses and safety of foot-and-mouth disease vaccine containing immunostimulating components in pigs
por: Choi, Joo-Hyung, et al.
Publicado: (2020)

Advanced Foot-And-Mouth Disease Vaccine Platform for Stimulation of Simultaneous Cellular and Humoral Immune Responses
por: Lee, Min Ja, et al.
Publicado: (2020)

Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation
por: Ekanayaka, Pathum, et al.
Publicado: (2020)

Foot-and-Mouth Disease Virus 3C Protease Antagonizes Interferon Signaling and C142T Substitution Attenuates the FMD Virus
por: Ekanayaka, Pathum, et al.
Publicado: (2021)

The HSP70-fused foot-and-mouth disease epitope elicits cellular and humoral immunity and drives broad-spectrum protective efficacy
por: Jo, Hyundong, et al.
Publicado: (2021)

Foot-and-Mouth Disease Virus 3C(pro) Cleaves BP180 to Induce Blister Formation
por: Ekanayaka, Pathum, et al.
Publicado: (2022)

The C3d-fused foot-and-mouth disease vaccine platform overcomes maternally-derived antibody interference by inducing a potent adaptive immunity
por: Lee, Min Ja, et al.
Publicado: (2022)

Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs
por: Jo, Hye-Eun, et al.
Publicado: (2019)

Inhibition of MAVS Aggregation-Mediated Type-I Interferon Signaling by Foot-and-Mouth Disease Virus VP3
por: Ekanayaka, Pathum, et al.
Publicado: (2021)

Immunogenicity and Protection against Foot-and-Mouth Disease Virus in Swine Intradermally Vaccinated with a Bivalent Vaccine of Foot-and-Mouth Disease Virus Type O and A
por: Kim, Dong-Wan, et al.
Publicado: (2023)

New foot-and-mouth disease vaccine, O JC-R, induce complete protection to pigs against SEA topotype viruses occurred in South Korea, 2014–2015
por: Jo, Hye-Eun, et al.
Publicado: (2019)

Serological Conversion through a Second Exposure to Inactivated Foot-and-Mouth Disease Virus Expressing the JC Epitope on the Viral Surface
por: Hwang, Seong Yun, et al.
Publicado: (2023)

Foot-and-mouth disease virus non-structural protein 2B downregulates the RLR signaling pathway via degradation of RIG-I and MDA5
por: Weerawardhana, Asela, et al.
Publicado: (2022)

Evaluation of Vaccine Strains Developed for Efficient, Broad-Range Protection against Foot-and-Mouth Disease Type O
por: Hwang, Seong Yun, et al.
Publicado: (2023)

Adjuvanticity of Processed Aloe vera gel for Influenza Vaccination in Mice
por: Song, Eun-Jung, et al.
Publicado: (2020)

Validation of Pretreatment Methods for the In-Process Quantification of Foot-and-Mouth Disease Vaccine Antigens
por: Kim, Ah-Young, et al.
Publicado: (2021)

African swine fever virus B175L inhibits the type I interferon pathway by targeting STING and 2′3′-cGAMP
por: Ranathunga, Lakmal, et al.
Publicado: (2023)

Reemergence of Foot-and-Mouth Disease, South Korea, 2000–2011
por: Park, Jong-Hyeon, et al.
Publicado: (2014)

Bovine Genome-wide Association Study for Genetic Elements to Resist the Infection of Foot-and-mouth Disease in the Field
por: Lee, Bo-Young, et al.
Publicado: (2015)

Efficacy of Binary Ethylenimine in the Inactivation of Foot-and-Mouth Disease Virus for Vaccine Production in South Korea
por: Kim, Jae Young, et al.
Publicado: (2023)

Preventive effects of quercetin against foot-and-mouth disease virus in vitro and in vivo by inducing type I interferon
por: Lee, Gyeongmin, et al.
Publicado: (2023)

Needleless intradermal vaccination for foot-and-mouth disease induced granuloma-free effective protection in pigs
por: Hwang, Ji-Hyeon, et al.
Publicado: (2019)

The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine
por: Ko, Mi-Kyeong, et al.
Publicado: (2023)

Efficient Removal of Non-Structural Protein Using Chloroform for Foot-and-Mouth Disease Vaccine Production
por: Park, Sun Young, et al.
Publicado: (2020)

Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-α and antiviral agents
por: Kim, Su-Mi, et al.
Publicado: (2012)

Analysis of Amino Acid Mutations of the Foot-and-Mouth Disease Virus Serotype O Using both Heparan Sulfate and JMJD6 Receptors
por: Lee, Gyeongmin, et al.
Publicado: (2020)

Adjuvants and adjuvanticity
por: Tizard, Ian R.
Publicado: (2021)

Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses
por: Lee, Seo-Yong, et al.
Publicado: (2017)

Risk Factors for Neurologic Complications of Hand, Foot and Mouth Disease in the Republic of Korea, 2009
por: Kim, Seong Joon, et al.
Publicado: (2013)

Novel foot-and-mouth disease virus in Korea, July-August 2014
por: Park, Jong-Hyeon, et al.
Publicado: (2016)

Requirements for improved vaccines against foot-and-mouth disease epidemics
por: Park, Jong-Hyeon
Publicado: (2013)

Foot-and-Mouth Disease Virus Evades Innate Immune Response by 3C-Targeting of MDA5
por: Kim, Hyejin, et al.
Publicado: (2021)

Comparison of High-Performance Liquid Chromatography with Sucrose Density Gradient Ultracentrifugation for the Quantification of Foot-and-Mouth Disease Vaccine Antigens
por: Kim, Ah-Young, et al.
Publicado: (2022)

Control of type O foot-and-mouth disease by vaccination in Korea, 2014–2015
por: Park, Jong-Hyeon, et al.
Publicado: (2018)

Development of a Potent Stabilizer for Long-Term Storage of Foot-and-Mouth Disease Vaccine Antigens
por: Kim, Ah-Young, et al.
Publicado: (2021)

Recombinant DNA and Protein Vaccines for Foot-and-mouth Disease Induce Humoral and Cellular Immune Responses in Mice
por: Bae, Ji-young, et al.
Publicado: (2009)

Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus
por: Park, Sun Young, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rqi9un5fb84fr2pgeppos8dlf8